Question: Should I be concerned that there may be a shortage of medications for hepatitis B and C patients during the COVID-19 outbreak?

Answer passage (source: CDC):
page_title: What to Know About Liver Disease and COVID-19
section_headers: Are people with hepatitis B virus or hepatitis C at higher risk for COVID-19 than other people?
section_content: Currently, we have no information about whether people with hepatitis B or
hepatitis C are at increased risk for getting COVID-19 or having severe
COVID-19. However, based on available information and clinical expertise,
older adults and people of any age who have serious underlying medical
conditions, including people with liver disease, might be at higher risk for
severe illness from COVID-19, particularly if the underlying medical
conditions are not well controlled.

Reviewer feedback on this answer:
It does not answer anything about medications. Instead it goes into whether people with Hepatitis are at greater risk for getting COVID-19, which was not asked.
The original question was about anticipated shortages in the drugs used to treat hep B and C, not the likelihood that people with these illnesses would contract Covid.

Reviewer ratings:
Bad
Bad

Answer passage (source: CDC):
page_title: What to Know About Liver Disease and COVID-19
section_headers: Are shortages of hepatitis B or hepatitis C medicine expected?
section_content: No drug shortages or anticipated problems with medicine used to treat
hepatitis B or hepatitis C have been identified to date.
The U.S. Food and Drug Administration (FDA) is closely monitoring the drug
supply chain because the COVID-19 outbreak has the potential to disrupt the
supply of medical and pharmaceutical products in the United States.
Learn more about the FDA’s response to COVID-19external
icon and information on drug shortagesexternal
icon.

Reviewer feedback on this answer:
It answers the question by saying there have been no reported shortages to date, and then explains that medications are being closely monitored due to the potential of supply disruption during the pandemic.
The response gives a clear answer that is quick and to the point, although there appears to be some conflicting information.

Reviewer ratings:
Excellent
Acceptable

Answer passage (source: CDC):
page_title: What to Know About Liver Disease and COVID-19
section_headers: Can antivirals used to treat hepatitis B or hepatitis C be used to treat COVID-19?
section_content: We do not know at this time. Currently there are no drugs approved by the
U.S. Food and Drug Administration (FDA)external
icon specifically for the treatment of COVID-19, although FDA has
granted an Emergency Use Authorization for the use of remdesivir to treat
severe cases. Remdesivir is not used to treat hepatitis B or hepatitis C.
Researchers are studying new drugs and drugs that are already approved for
other health conditions to determine their safety and effectiveness in
treating COVID-19. In the meantime, never take a prescription medicine or drug
if it is not prescribed for you by your doctor for your health condition.

Reviewer feedback on this answer:
It does not address the question at all. It explains how there is no treatment for COVID-19 , and mentions a non-Hepatitis related drug that treats severe COVID-19 cases. Nowhere does it answer the question that is asked about the potential for shortage of Hepatitis B/C drugs during the COVID-19 pandemic.
The article mentions hepatitis B and C but seems to be about drugs that are used specifically to treat Covid rather than the conditions mentioned in the question.

Reviewer ratings:
Bad
Bad